Evolving regulatory requirements and ensuring product sterility and stability are driving demand for packaging innovation, particularly for biologic medicines, research suggests.
Growing demand for biologics, vaccines and injectable therapies is expected to drive continued growth across the pharmaceutical packaging sector, according to the Pharmaceutical Glass Packaging Industry Analysis Report 2026: Key Trends, Drivers, and Forecast Insights, published earlier this year by The Business Research Company.
According to the report, pharmaceutical manufacturers are increasingly seeking packaging solutions that can support sterility, product stability and regulatory compliance as more complex therapies move through development and into commercial production.
The findings reflect wider changes across the pharmaceutical industry… [including] the growing importance of biologics within pharmaceutical pipelines, creating new challenges for manufacturing, storage and distribution”
The findings reflect wider changes across the pharmaceutical industry. A recent analysis from CPHI, The evolving biotech ecosystem and the rise of biologics, highlighted the growing importance of biologics within pharmaceutical pipelines, creating new challenges for manufacturing, storage and distribution.
As a result, packaging is increasingly being viewed as a critical component of product performance rather than simply a means of containment. In an article examining trends in biopharmaceutical packaging, BioPharm International noted a shift “from containment to protection” as manufacturers seek to safeguard increasingly sensitive biologic products.
The Business Research Company’s report identifies continued growth in demand for injectable drug delivery formats, including vials, prefilled syringes and cartridges. These formats are becoming increasingly important as pharmaceutical companies expand manufacturing capacity for biologics and other advanced therapies.
Industry analysts also point to growing demand for packaging technologies that support automation, traceability and supply chain resilience. According to Coherent Market Insights report, Pharmaceutical Packaging Market Analysis and Forecast: 2026-2033, biologics, personalised medicines and self-administered therapies are contributing to increased demand for advanced pharmaceutical packaging solutions.
The trend is expected to influence investment decisions across the pharmaceutical value chain, including drug manufacturers, contract development and manufacturing organisations (CDMOs) and packaging technology providers.
While glass remains the dominant packaging material for many injectable medicines, manufacturers are also exploring specialised polymer formats and advanced container technologies designed to improve product stability and patient convenience.
According to the Business Research Insights report, continued growth in biologics and other complex therapies is likely to remain a major driver of pharmaceutical packaging innovation over the coming decade as manufacturers balance evolving regulatory requirements with the need to protect increasingly sensitive medicines.
No comments yet